Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects

M. Bialer, A. Haj-Yehia, N. Barzaghi, F. Pisani, E. Perucca

Research output: Contribution to journalArticle

Abstract

The pharmacokinetics of a single 400 mg oral dose of valnoctamide (VCD) has been investigated in seven healthy, adult, male volunteers. VCD was not biotransformed rapidly to its corresponding acid valnoctic acid (VCA), unlike its isomer valpromide (VPD). It had a mean residence time of 13.2 h and a terminal half-life of 9.3 h. Throughout the study, only low plasma levels of VCA could be detected. Thus, unlike VPD, which is a prodrug of the corresponding acid, (valproic acid, VPA). VCD appears to act as a drug in its own right, and it does not undergo similar hydrolysis. The pharmacokinetic difference may account for the different pharmacological activities of the two isomers.

Original languageEnglish
Pages (from-to)289-291
Number of pages3
JournalEuropean Journal of Clinical Pharmacology
Volume38
Issue number3
DOIs
Publication statusPublished - Mar 1990

Fingerprint

Healthy Volunteers
Pharmacokinetics
Acids
Prodrugs
Valproic Acid
Half-Life
Volunteers
Hydrolysis
Pharmacology
Pharmaceutical Preparations
valnoctamide
dipropylacetamide
valnoctic acid

Keywords

  • healthy subjects
  • pharmacokinetics
  • tranquiliser
  • valnoctamide
  • valproic acid
  • valpromide

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects. / Bialer, M.; Haj-Yehia, A.; Barzaghi, N.; Pisani, F.; Perucca, E.

In: European Journal of Clinical Pharmacology, Vol. 38, No. 3, 03.1990, p. 289-291.

Research output: Contribution to journalArticle

Bialer, M. ; Haj-Yehia, A. ; Barzaghi, N. ; Pisani, F. ; Perucca, E. / Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects. In: European Journal of Clinical Pharmacology. 1990 ; Vol. 38, No. 3. pp. 289-291.
@article{9fb25bdbbcad43dba6ba9239e04be1c7,
title = "Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects",
abstract = "The pharmacokinetics of a single 400 mg oral dose of valnoctamide (VCD) has been investigated in seven healthy, adult, male volunteers. VCD was not biotransformed rapidly to its corresponding acid valnoctic acid (VCA), unlike its isomer valpromide (VPD). It had a mean residence time of 13.2 h and a terminal half-life of 9.3 h. Throughout the study, only low plasma levels of VCA could be detected. Thus, unlike VPD, which is a prodrug of the corresponding acid, (valproic acid, VPA). VCD appears to act as a drug in its own right, and it does not undergo similar hydrolysis. The pharmacokinetic difference may account for the different pharmacological activities of the two isomers.",
keywords = "healthy subjects, pharmacokinetics, tranquiliser, valnoctamide, valproic acid, valpromide",
author = "M. Bialer and A. Haj-Yehia and N. Barzaghi and F. Pisani and E. Perucca",
year = "1990",
month = "3",
doi = "10.1007/BF00315032",
language = "English",
volume = "38",
pages = "289--291",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects

AU - Bialer, M.

AU - Haj-Yehia, A.

AU - Barzaghi, N.

AU - Pisani, F.

AU - Perucca, E.

PY - 1990/3

Y1 - 1990/3

N2 - The pharmacokinetics of a single 400 mg oral dose of valnoctamide (VCD) has been investigated in seven healthy, adult, male volunteers. VCD was not biotransformed rapidly to its corresponding acid valnoctic acid (VCA), unlike its isomer valpromide (VPD). It had a mean residence time of 13.2 h and a terminal half-life of 9.3 h. Throughout the study, only low plasma levels of VCA could be detected. Thus, unlike VPD, which is a prodrug of the corresponding acid, (valproic acid, VPA). VCD appears to act as a drug in its own right, and it does not undergo similar hydrolysis. The pharmacokinetic difference may account for the different pharmacological activities of the two isomers.

AB - The pharmacokinetics of a single 400 mg oral dose of valnoctamide (VCD) has been investigated in seven healthy, adult, male volunteers. VCD was not biotransformed rapidly to its corresponding acid valnoctic acid (VCA), unlike its isomer valpromide (VPD). It had a mean residence time of 13.2 h and a terminal half-life of 9.3 h. Throughout the study, only low plasma levels of VCA could be detected. Thus, unlike VPD, which is a prodrug of the corresponding acid, (valproic acid, VPA). VCD appears to act as a drug in its own right, and it does not undergo similar hydrolysis. The pharmacokinetic difference may account for the different pharmacological activities of the two isomers.

KW - healthy subjects

KW - pharmacokinetics

KW - tranquiliser

KW - valnoctamide

KW - valproic acid

KW - valpromide

UR - http://www.scopus.com/inward/record.url?scp=0025262283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025262283&partnerID=8YFLogxK

U2 - 10.1007/BF00315032

DO - 10.1007/BF00315032

M3 - Article

C2 - 2111246

AN - SCOPUS:0025262283

VL - 38

SP - 289

EP - 291

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 3

ER -